French Prospective Multicentre Non-Interventional Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice
Latest Information Update: 16 Dec 2021
At a glance
- Drugs Follitropin delta (Primary)
- Indications Female infertility
- Focus Adverse reactions; Therapeutic Use
- Acronyms DELTA
- Sponsors Ferring Pharmaceuticals
- 13 Dec 2021 Status changed from active, no longer recruiting to completed.
- 01 Nov 2021 Status changed from recruiting to active, no longer recruiting.
- 01 Jun 2021 Planned End Date changed from 1 Jul 2021 to 31 Oct 2021.